If youre taking a GLP-1 medication for weight loss, such as semaglutide or tirzepatide, you might have noticed your relationship with food has shifted
[2] Additionally, GLP-1 agonists have been shown to reduce markers of systemic inflammation, including C-reactive protein (CRP), in patients with type 2 diabetes and cardiovascular disease, though these reductions are often modest
These wider impacts are valuable for those suffering from metabolic issues or obesity-related wellness problems
For sensitive users, starting with one capsule and gradually increasing the dosage is often a smoother experience
It also acquired a U.S.-based peptide facility based in California last year to expand its production of peptide treatments
current Pulse width in s (micro-seconds) Frequency in Hz (hertz or cycles per second) Time how long to run the device